HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of giant cell hepatitis recurring after liver transplantation and treated with ribavirin.

Abstract
A patient who underwent orthotopic liver transplantation for giant cell hepatitis with cirrhosis and in whom giant cell hepatitis recurred twice after orthotopic liver transplantation is reported. He was treated with ribavirin with an excellent result. The literature on this subject is reviewed. This observation clearly confirms the efficacy of ribavirin for the treatment of giant cell hepatitis, thus providing evidence for its viral origin.
AuthorsZ Hassoun, B N'Guyen, J Cote, D Marleau, B Willems, A Roy, M Dagenais, R Lapointe, R Letourneau, J P Villeneuve
JournalCanadian journal of gastroenterology = Journal canadien de gastroenterologie (Can J Gastroenterol) Vol. 14 Issue 8 Pg. 729-31 (Sep 2000) ISSN: 0835-7900 [Print] Canada
PMID11185540 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antiviral Agents
  • Ribavirin
Topics
  • Adult
  • Antiviral Agents (therapeutic use)
  • Giant Cells (pathology)
  • Hepatitis (drug therapy, pathology, surgery)
  • Humans
  • Liver (pathology)
  • Liver Cirrhosis (surgery)
  • Liver Transplantation
  • Male
  • Recurrence
  • Ribavirin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: